Table 3.
Comorbidities and COVID-19 outcome.
| Characteristics | Total (n=115) |
Survivor
(n=64) |
Non-survivor
(n=51) |
Odd’s Ratio | Risk Ratio | p value |
|---|---|---|---|---|---|---|
| Male | 69(60%) | 33 (51.56%) | 36 (70.58%) | 1 (Ref.) | 1 (Ref.) | 0.02 |
| Female | 46(40%) | 31 (48.44%) | 15 (29.42%) | 0.4435 (0.20-0.96) | 0.62(0.389-1.002) | - |
| Age >40 | 96(83.47%) | 54 (84.37%) | 42 (82.35%) | 1 (Ref.) | 1 (Ref.) | - |
| Age ≤40 | 19(16.52%) | 10(15.62%) | 09 (17.30%) | 0.8642 (0.322-2.318) | 0.9236 (0.546-1.56) | 0.482 |
| T2DM | 47 (40.17%) | 08 (12.48%) | 39 (76.47%) | 22.75 (8.50- 60.834) | 4.70 2.769-7.984) | < 0.0001 |
| Hypertension | 37 (31.62%) | 06 (9.36%) | 31 (72.54%) | 14.98(5.450-41.187) | 3.26(2.182-4.892) | < 0.0001 |
| CAD | 17 (14.53%) | 00 (0) | 17 (33.33%) | - | 2.8(2.1967-3.782) | < 0.0001 |
| CKD | 11(9.4%) | 2 (3.12%) | 09 (17.64%) | 6.642(1.36-32.298) | 2.02(1.408-2.914) | < 0.009 |